Palisade Bio, Inc.
PALI
$0.7556
-$0.0207-2.67%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | -16.69% | -13.02% | 10.54% | -5.14% | 3.52% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 15.47% | -4.90% | 16.68% | 32.17% | -23.88% |
| Operating Income | -15.47% | 4.90% | -16.68% | -45.24% | 23.88% |
| Income Before Tax | -12.55% | 3.03% | -20.25% | -50.73% | 20.13% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -12.55% | 3.03% | -20.25% | -50.73% | 20.13% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -12.55% | 3.03% | -20.25% | -50.73% | 20.13% |
| EBIT | -15.47% | 4.90% | -16.68% | -45.24% | 23.88% |
| EBITDA | -15.47% | 4.90% | -16.72% | -45.25% | 23.84% |
| EPS Basic | 67.82% | 68.50% | 58.12% | 43.55% | 85.58% |
| Normalized Basic EPS | 65.18% | 68.36% | 58.12% | 43.55% | 85.64% |
| EPS Diluted | 67.82% | 68.50% | 58.12% | 43.55% | 85.60% |
| Normalized Diluted EPS | 65.18% | 68.36% | 58.12% | 43.55% | 85.64% |
| Average Basic Shares Outstanding | 249.81% | 206.45% | 187.10% | 166.98% | 413.98% |
| Average Diluted Shares Outstanding | 249.81% | 206.45% | 187.10% | 166.98% | 413.98% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |